These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26081142)

  • 21. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Rohn TT
    Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease.
    King A; Sweeney F; Bodi I; Troakes C; Maekawa S; Al-Sarraj S
    Neuropathology; 2010 Aug; 30(4):408-19. PubMed ID: 20102526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.
    Borroni B; Benussi A; Archetti S; Galimberti D; Parnetti L; Nacmias B; Sorbi S; Scarpini E; Padovani A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):86-91. PubMed ID: 25352065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
    Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
    Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new dementia group caused by TDP-43 abnormality].
    Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
    Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
    Yamashita M; Nonaka T; Arai T; Kametani F; Buchman VL; Ninkina N; Bachurin SO; Akiyama H; Goedert M; Hasegawa M
    FEBS Lett; 2009 Jul; 583(14):2419-24. PubMed ID: 19560462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
    Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Component of ubiquitin-positive inclusions in ALS].
    Hasegawa M; Arai T
    Brain Nerve; 2007 Oct; 59(10):1171-7. PubMed ID: 17969358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
    Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U
    Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.
    Baldeiras I; Santana I; Leitão MJ; Ribeiro MH; Pascoal R; Duro D; Lemos R; Santiago B; Almeida MR; Oliveira CR
    J Neurol Sci; 2015 Nov; 358(1-2):308-16. PubMed ID: 26388316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism.
    Jung Y; Dickson DW; Murray ME; Whitwell JL; Knopman DS; Boeve BF; Jack CR; Parisi JE; Petersen RC; Josephs KA
    J Neurol; 2014 Jul; 261(7):1344-8. PubMed ID: 24760339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of casein kinase 1ε associated with TDP-43 and tau pathologies in Alzheimer's disease.
    Gu J; Hu W; Tan X; Qu S; Chu D; Gong CX; Iqbal K; Liu F
    Brain Pathol; 2020 Mar; 30(2):283-297. PubMed ID: 31376192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits.
    Ohta Y; Tremblay C; Schneider JA; Bennett DA; Calon F; Julien JP
    Acta Neuropathol Commun; 2014 Apr; 2():37. PubMed ID: 24690380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.
    Toyoshima Y; Takahashi H
    Neuropathology; 2014 Feb; 34(1):77-82. PubMed ID: 23889603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
    Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.